Reviewed,
UniProtKB/Swiss-Prot P00617 (PA21B_BUNMU)
Last modified
June 16, 2009.
Version 89.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Phospholipase A2, beta bungarotoxin A1 chain EC=3.1.1.4 Alternative name(s): Phosphatidylcholine 2-acylhydrolase |
| Organism | Bungarus multicinctus (Many-banded krait) |
| Taxonomic identifier | 8616 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Lepidosauria › Squamata › Scleroglossa › Serpentes › Colubroidea › Elapidae › Bungarinae › Bungarus |
Protein attributes
| Sequence length | 147 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. Acts presynaptically. |
| Catalytic activity | Phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. |
| Cofactor | Binds 1 calcium ion By similarity. |
| Subunit structure | Heterodimer; disulfide-linked. The A chains have phospholipase A2 activity and the B chains show homology with the basic protease inhibitors. The A1 chain is found in beta-1 and beta-2 bungarotoxins. Ref.9 |
| Subcellular location | |
| Tissue specificity | Expressed by the venom gland. |
| Toxic dose | LD50 is 0.019 mg/kg by intraperitoneal injection in beta-1 bungarotoxin and 0.028 mg/kg in beta-2. |
| Sequence similarities | Belongs to the phospholipase A2 family. Group I subfamily. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Lipid degradation |
| Cellular component | Secreted |
| Domain | Signal |
| Ligand | Calcium Metal-binding |
| Molecular function | Hydrolase Neurotoxin Presynaptic neurotoxin Toxin |
| PTM | Disulfide bond |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | lipid catabolic process Inferred from electronic annotation. Source: UniProtKB-KW pathogenesisInferred from electronic annotation. Source: UniProtKB-KW phospholipid metabolic processInferred from electronic annotation. Source: InterPro synaptic transmissionInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell presynaptic membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | calcium ion binding Inferred from electronic annotation. Source: UniProtKB-KW phospholipase A2 activityInferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 19 | 19 | Potential | ||||||||||||||||||||||||||||
| Propeptide | 20 – 27 | 8 | Ref.4 Ref.5 | PRO_0000022835 | |||||||||||||||||||||||||||
| Chain | 28 – 147 | 120 | Phospholipase A2, beta bungarotoxin A1 chain | PRO_0000022836 | |||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||
| Active site | 75 | 1 | By similarity | ||||||||||||||||||||||||||||
| Active site | 121 | 1 | By similarity | ||||||||||||||||||||||||||||
| Metal binding | 55 | 1 | Calcium; via carbonyl oxygen | ||||||||||||||||||||||||||||
| Metal binding | 57 | 1 | Calcium; via carbonyl oxygen | ||||||||||||||||||||||||||||
| Metal binding | 59 | 1 | Calcium; via carbonyl oxygen | ||||||||||||||||||||||||||||
| Metal binding | 76 | 1 | Calcium | ||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||
| Disulfide bond | 42 | Interchain (with a B chain) Ref.9 | |||||||||||||||||||||||||||||
| Disulfide bond | 54 ↔ 146 | Ref.9 | |||||||||||||||||||||||||||||
| Disulfide bond | 56 ↔ 72 | Ref.9 | |||||||||||||||||||||||||||||
| Disulfide bond | 71 ↔ 127 | Ref.9 | |||||||||||||||||||||||||||||
| Disulfide bond | 78 ↔ 120 | Ref.9 | |||||||||||||||||||||||||||||
| Disulfide bond | 88 ↔ 113 | Ref.9 | |||||||||||||||||||||||||||||
| Disulfide bond | 106 ↔ 118 | Ref.9 | |||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||
| Natural variant | 116 | 1 | I → V in 20% of the molecules. | ||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||
| Mutagenesis | 42 | 1 | C → S: Loss of PA2 activity. No loss in Ca(2+)-binding ability. Weak loss in folding. Ref.3 | ||||||||||||||||||||||||||||
| Sequence conflict | 10 | 1 | S → L in CAB62164. Ref.2 | ||||||||||||||||||||||||||||
| Sequence conflict | 93 – 94 | 2 | QS → SQ Ref.4 | ||||||||||||||||||||||||||||
| Sequence conflict | 93 – 94 | 2 | QS → SQ Ref.5 | ||||||||||||||||||||||||||||
| Sequence conflict | 114 | 1 | G → A Ref.9 | ||||||||||||||||||||||||||||
| Sequence conflict | 130 – 132 | 3 | NSE → QSD Ref.4 | ||||||||||||||||||||||||||||
| Sequence conflict | 130 – 132 | 3 | NSE → QSD Ref.5 | ||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||
| Helix | 29 – 37 | 9 | |||||||||||||||||||||||||||||
| Helix | 47 – 50 | 4 | |||||||||||||||||||||||||||||
| Turn | 53 – 55 | 3 | |||||||||||||||||||||||||||||
| Beta strand | 56 – 58 | 3 | |||||||||||||||||||||||||||||
| Helix | 67 – 83 | 17 | |||||||||||||||||||||||||||||
| Turn | 84 – 86 | 3 | |||||||||||||||||||||||||||||
| Turn | 90 – 92 | 3 | |||||||||||||||||||||||||||||
| Beta strand | 97 – 100 | 4 | |||||||||||||||||||||||||||||
| Beta strand | 103 – 106 | 4 | |||||||||||||||||||||||||||||
| Helix | 113 – 130 | 18 | |||||||||||||||||||||||||||||
| Helix | 135 – 137 | 3 | |||||||||||||||||||||||||||||
| Helix | 142 – 145 | 4 | |||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Genomic organization of the genes encoding the A chains of beta-bungarotoxins." Chang L.-S., Chu Y.P. Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Venom gland. |
| [2] | "Genetic organization of A chain and B chain of beta-bungarotoxin from Taiwan banded krait (Bungarus multicinctus). A chain genes and B chain genes do not share a common origin." Wu P.-F., Chang L.-S. Eur. J. Biochem. 267:4668-4675(2000) [PubMed: 10903499] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 10-147. Tissue: Liver. |
| [3] | "Expression of A chain and B chain of beta-bungarotoxin from taiwan banded krait: the functional implication of the interchain disulfide bond between A chain and B chain." Wu P.-F., Chang L.-S. J. Protein Chem. 20:413-421(2001) [PubMed: 11732693] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 11-147, MUTAGENESIS OF CYS-42. Tissue: Venom gland. |
| [4] | "Amino acid sequences of the two polypeptide chains in beta1-bungarotoxin from the venom of Bungarus multicinctus." Kondo K., Narita K., Lee C.-Y. J. Biochem. 83:101-115(1978) [PubMed: 624701] [Abstract] Cited for: PROTEIN SEQUENCE OF 28-147. Tissue: Venom. |
| [5] | "Amino acid sequence of beta 2-bungarotoxin from Bungarus multicinctus venom. The amino acid substitutions in the B chains." Kondo K., Toda H., Narita K., Lee C.-Y. J. Biochem. 91:1519-1530(1982) [PubMed: 7096304] [Abstract] Cited for: PROTEIN SEQUENCE OF 28-147, SEQUENCE REVISION TO 112-114 AND 136. |
| [6] | "Characterization of phospholipase A activity of beta1-bungarotoxin from Bungarus multicinctus venom. II. Identification of the histidine residue of beta1-bungarotoxin modified by p-bromophenacyl bromide." Kondo K., Toda H., Narita K. J. Biochem. 84:1301-1308(1978) [PubMed: 730754] [Abstract] Cited for: CHARACTERIZATION OF PHOSPHOLIPASE A2 ACTIVITY. |
| [7] | "Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes." Abe T., Alema S., Miledi R. Eur. J. Biochem. 80:1-12(1977) [PubMed: 303565] [Abstract] Cited for: CHARACTERIZATION OF PRESYNAPTIC NEUROTOXINS. |
| [8] | "What does beta-bungarotoxin do at the neuromuscular junction?" Rowan E.G. Toxicon 39:107-118(2001) [PubMed: 10936627] [Abstract] Cited for: REVIEW. |
| [9] | "Structure of beta 2-bungarotoxin: potassium channel binding by Kunitz modules and targeted phospholipase action." Kwong P.D., McDonald N.Q., Sigler P.B., Hendrickson W.A. Structure 3:1109-1119(1995) [PubMed: 8590005] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 28-147, METAL-BINDING SITES, DISULFIDE BONDS. Tissue: Venom. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AJ431711 mRNA. Translation: CAD24466.1. AJ251360 Genomic DNA. Translation: CAB62164.1. AJ242011 mRNA. Translation: CAB62383.1. | |||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P00617. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 3.1.1.4. 81621. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR016090. Phospholipase_A2. IPR013090. Phospholipase_A2_AS. IPR001211. Phospholipase_A2_euk. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:1.20.90.10. Phospholipase_A2. 1 hit. | ||||||||||||
| PANTHER | PTHR11716. Phospholipase_A2. 1 hit. | ||||||||||||
| Pfam | PF00068. Phospholip_A2_1. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00389. PHPHLIPASEA2. | ||||||||||||
| ProDom | PD000303. PhospholipaseA2. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00085. PA2c. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00119. PA2_ASP. 1 hit. PS00118. PA2_HIS. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Entry information
| Entry name | PA21B_BUNMU | ||||||||
| Accession | Primary (citable) accession number: P00617 Secondary accession number(s): Q8QFN8, Q9PU95, Q9PU98 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


